What does CUSIP 74907L102 represent in this 13F holders report?

CUSIP 74907L102 is the security identifier for QNRX - QUOIN PHARMACEUTICALS LTD - SPON ADS NEW 21 used to aggregate holder disclosures.

How many institutions held QNRX - QUOIN PHARMACEUTICALS LTD - SPON ADS NEW 21 in Q2 2022?

7 institutional investors reported QNRX - QUOIN PHARMACEUTICALS LTD - SPON ADS NEW 21 for Q2 2022. Use the holders table for investor-level position and value details.

QUOIN PHARMACEUTICALS LTD - SPON ADS NEW 21 (QNRX)

CUSIP: 74907L102

Q2 2022 13F Holders as of 30 Jun 2022

Security type / class: Equity / SPON ADS NEW 21
Total 13F shares: 147,917
Total 13F value: $65,000
Share change: +25,355
SEC-reported price per share: $0.43
Number of holders: 7
Value change: -$26,417
Number of buys: 5
Number of sells: 2

Security key

74907L102

Report period

Q2 2022

Institutions

Top holders

QNRX full security history Ownership snapshot Full 13F holder table Quoin Pharmaceuticals Ltd. SEC filings Quoin Pharmaceuticals Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of QNRX - QUOIN PHARMACEUTICALS LTD - SPON ADS NEW 21 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

AMERIPRISE FINANCIAL INC

Disclosed value leader

AMERIPRISE FINANCIAL INC

Comparable rows

0/5

Latest evidence

31 Mar 2022

13F Highest disclosed value: $256,000 5 rows are not safely comparable across share classes.

Quick read

AMERIPRISE FINANCIAL INC has the largest disclosed position value at $256K.

0 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AMERIPRISE FINANCIAL INC's linked filing trail.

Disclosed position value Top 5

AMERIPRISE FINANCIAL INC $256K

RENAISSANCE TECHNOLOGIES LLC $67K

Virtu Financial LLC $57K

HRT FINANCIAL LP $20K

GEODE CAPITAL MANAGEMENT, LLC $19K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-5 of 5 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
AMERIPRISE FINANCIAL INC	13F Company 13F	— denominator unverified	$256,000 22,000 shares	—	31 Mar 2022
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$67,000 50,400 shares	—	31 Mar 2022
Virtu Financial LLC	13F Company 13F	— denominator unverified	$57,000 42,665 shares	—	31 Mar 2022
HRT FINANCIAL LP	13F Company 13F	— denominator unverified	$20,000 15,105 shares	—	31 Mar 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$19,000 14,392 shares	—	31 Mar 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

147,917

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q2 2022 value	Value change	Value Chg %